| 000 | 01565 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250513135303.0 | ||
| 264 | 0 | _c19980313 | |
| 008 | 199803s 0 0 eng d | ||
| 022 | _a0009-9104 | ||
| 024 | 7 |
_a10.1046/j.1365-2249.1998.00510.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSampaio, E P | |
| 245 | 0 | 0 |
_aPentoxifylline decreases in vivo and in vitro tumour necrosis factor-alpha (TNF-alpha) production in lepromatous leprosy patients with erythema nodosum leprosum (ENL). _h[electronic resource] |
| 260 |
_bClinical and experimental immunology _cFeb 1998 |
||
| 300 |
_a300-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aErythema Nodosum _xdrug therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGene Expression _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLeprosy, Lepromatous _xdrug therapy |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aPentoxifylline _xtherapeutic use |
| 650 | 0 | 4 |
_aPhosphodiesterase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 | _aPolymerase Chain Reaction |
| 650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xbiosynthesis |
| 700 | 1 | _aMoraes, M O | |
| 700 | 1 | _aNery, J A | |
| 700 | 1 | _aSantos, A R | |
| 700 | 1 | _aMatos, H C | |
| 700 | 1 | _aSarno, E N | |
| 773 | 0 |
_tClinical and experimental immunology _gvol. 111 _gno. 2 _gp. 300-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-2249.1998.00510.x _zAvailable from publisher's website |
| 999 |
_c9454569 _d9454569 |
||